©2018 WebMD, Inc. All rights reserved. eMedicineHealth does not provide medical advice, diagnosis or treatment. See Additional Information.

New Zealand Green-Lipped Mussel

What other names is New Zealand Green-lipped Mussel known by?

Extrait de Moule, GLM, Green Lipped Mussel, Green Shell Mussel, Mejillón Verde de Nueva Zealandia, Moule à Coquille Verte, Moule à Coquille Verte de Nouvelle-Zélande, Moule aux Lèvres Verte de Nouvelle-Zélande, Moule Vert-Labiée de Nouvelle-Zélande, Moule Verte de Nouvelle-Zélande, Mussel Extract, New Zealand Green Lipped Sea Mussel, New Zealand Green Mollusk, NZGLM, Perna canaliculus, Sea Mussel, Seatone.

What is New Zealand Green-lipped Mussel?

New Zealand green-lipped mussel is a shellfish. People use it to make medicine. As a medicine, it is available in freeze-dried, ground, and capsule form.

New Zealand green-lipped mussel is used for rheumatoid arthritis, osteoarthritis, and asthma.

Insufficient Evidence to Rate Effectiveness for...

  • Asthma. Developing research suggests that a particular extract of New Zealand green-lipped mussel (Lyprinol, Pharmalink) decreases daytime wheezing and improves breathing in some people with asthma.
  • Osteoarthritis. Early research suggests that taking New Zealand green-lipped mussel extract by mouth reduces symptoms of osteoarthritis, including pain and stiffness. However, other research shows little or no benefit. Most studies have used a specific extract of New Zealand green-lipped mussel (Seatone, MacFarland Laboratories), although some studies used another specific extract of New Zealand green-lipped mussels (Lyprinol, Pharmalink).
  • Rheumatoid arthritis (RA). Some early research suggests that taking a specific extract of New Zealand green-lipped mussel (Seatone, McFarlane Laboratories) by mouth reduces symptoms of RA, including pain and stiffness. However, other research shows no benefit.
  • Other conditions.
More evidence is needed to rate the effectiveness of New Zealand green-lipped mussels for these uses.

How does New Zealand Green-lipped Mussel work?

New Zealand green-lipped mussel might contain chemicals that help decrease inflammation.

Are there safety concerns?

New Zealand green-lipped mussel is POSSIBLY SAFE for most people when taken by mouth. It can cause some side effects such as diarrhea, nausea, and intestinal gas. In rare cases, it might cause liver problems.

Special Precautions & Warnings:

Pregnancy and breast-feeding: New Zealand green-lipped mussel is POSSIBLY UNSAFE to take by mouth during pregnancy. There is some evidence that it might slow the development of the unborn child and might also delay birth.

There is not enough reliable information about the safety of taking New Zealand green-lipped mussel if you are breast-feeding. Stay on the safe side and avoid use.

Dosing considerations for New Zealand Green-lipped Mussel.

The appropriate dose of New Zealand green-lipped mussel depends on several factors such as the user's age, health, and several other conditions. At this time there is not enough scientific information to determine an appropriate range of doses for New Zealand green-lipped mussel. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult your pharmacist or physician or other healthcare professional before using.

SLIDESHOW

Vitamin D Deficiency: How Much Vitamin D Is Enough? See Slideshow

Natural Medicines Comprehensive Database rates effectiveness based on scientific evidence according to the following scale: Effective, Likely Effective, Possibly Effective, Possibly Ineffective, Likely Ineffective, and Insufficient Evidence to Rate (detailed description of each of the ratings).

Health Solutions From Our Sponsors

Reviewed on 9/17/2019
References

Ahern, M. J., Milazzo, S. C., and Dymock, R. Granulomatous hepatitis and Seatone. Med J Aust 8-9-1980;2(3):151-152. View abstract.

Audeval, B. and Bouchacourt, P. Etude contrôlée, en double aveugle contre placebo, de l'extrait de moule Perna canaliculus (moule aux orles verts) dans la gonarthose (Double blind, placebo-controlled study of the mussel Perna canaliculus (New Zealand green-lipped mussel) in arthritis of the knee). La Gazette 1986;93:111-116.

Bierer, T. L. and Bui, L. M. Improvement of arthritic signs in dogs fed green-lipped mussel (Perna canaliculus). J Nutr 2002;132(6 Suppl 2):1634S-1636S. View abstract.

Brien, S., Prescott, P., Coghlan, B., Bashir, N., and Lewith, G. Systematic review of the nutritional supplement Perna Canaliculus (green-lipped mussel) in the treatment of osteoarthritis. QJM. 2008;101(3):167-179. View abstract.

Brooks, P. M. Side effects from Seatone. Med J Aust 8-9-1980;2(3):158. View abstract.

Bui, L. M. and Bierer, T. L. Influence of green lipped mussels (Perna canaliculus) in alleviating signs of arthritis in dogs. Vet.Ther 2003;4(4):397-407. View abstract.

Cho, S. H., Jung, Y. B., Seong, S. C., Park, H. B., Byun, K. Y., Lee, D. C., Song, E. K., and Son, J. H. Clinical efficacy and safety of Lyprinol, a patented extract from New Zealand green-lipped mussel (Perna Canaliculus) in patients with osteoarthritis of the hip and knee: a multicenter 2-month clinical trial. Eur Ann Allergy Clin Immunol 2003;35(6):212-216. View abstract.

Croft, J. E. Granulomatous hepatitis and Seatone. Med J Aust 10-4-1980;2(7):401-402. View abstract.

Darlington, L. G. and Ramsey, N. W. Review of dietary therapy for rheumatoid arthritis. Compr.Ther 1994;20(9):490-494. View abstract.

Dugas, B. Lyprinol inhibits LTB4 production by human monocytes. Allerg.Immunol (Paris) 2000;32(7):284-289. View abstract.

Fabrin, B. [Possible toxic hepatitis after intake of an alternative preparation]. Ugeskr.Laeger 6-13-1988;150(24):1474-1475. View abstract.

Gibson SL and Gibson RG. The treatment of arthritis with a lipid extract of Perna canaliculus: a randomised trial. Comp Ther Med 1998;6:122-126.

Gibson, R. G. and Gibson, S. L. Green-lipped mussel extract in arthritis. Lancet 2-21-1981;1(8217):439. View abstract.

Gibson, R. G. and Gibson, S. L. New Zealand green-lipped mussel extract (Seatone) in rheumatoid arthritis. N Z Med J 7-22-1981;94(688):67-68. View abstract.

Gibson, R. G. and Gibson, S. L. Seatone in arthritis. Br Med J (Clin Res Ed) 5-30-1981;282(6278):1795. View abstract.

Gibson, R. G. and Gibson, S. L. Seatone in rheumatoid arthritis. Ann Rheum Dis 1985;44(9):645-646. View abstract.

Glass, W. I., Power, P., Burt, R., Fishwick, D., Bradshaw, L. M., and Pearce, N. E. Work-related respiratory symptoms and lung function in New Zealand mussel openers. Am J Ind Med 1998;34(2):163-168. View abstract.

Green-lipped mussel extract in arthritis. Lancet 1-10-1981;1(8211):85. View abstract.

Greening, G. E., Dawson, J., and Lewis, G. Survival of poliovirus in New Zealand green-lipped mussels, Perna canaliculus, on refrigerated and frozen storage. J Food Prot. 2001;64(6):881-884. View abstract.

Gruenwald, J., Graubaum, H., Hansen, K., and Grube, B. Efficacy and tolerability of a combination of LYPRINOL and high concentrations of EPA and DHA in inflammatory rheumatoid disorders... eicosapentaenoic acid... decosahexaenoid acid. Advances in Therapy 2004;21(3):197-201.

Halliday, J. Not all green lipped mussel extracts are created equal. NutraIngredients.com Europe. Nutra Ingredients - Europe 2008;

Halpern, C. and Georges, M. Anti-inflammatory Effects of a Stabilized Lipid Extract of Perna Canaliculus (Lyprinol). Townsend Letter for Doctors & Patients 2000;(202):109-113.

Halpern, G. M. Anti-inflammatory effects of a stabilized lipid extract of Perna canaliculus (Lyprinol). Allerg.Immunol (Paris) 2000;32(7):272-278. View abstract.

Ishida, H., Nozawa, A., Nukaya, H., Rhodes, L., McNabb, P., Holland, P. T., and Tsuji, K. Confirmation of brevetoxin metabolism in cockle, Austrovenus stutchburyi, and greenshell mussel, Perna canaliculus, associated with New Zealand neurotoxic shellfish poisoning, by controlled exposure to Karenia brevis culture. Toxicon 2004;43(6):701-712. View abstract.

Jacobs, J. W., Rasker, J. J., Van Riel, P. L., Gribnau, F. W., and van de Putte, L. B. [Alternative treatment methods in rheumatic diseases; a literature review]. Ned.Tijdschr.Geneeskd. 2-23-1991;135(8):317-322. View abstract.

Kendall, R. V., Lawson, J. W., and Hurley, L. A. New research and a clinical report on the use of Perna canaliculus in the management of arthritis. Townsend Lett Dr Patients 2000;204(98):111.

Kosuge, T., Tsuji, K., Ishida, H., and Yamaguchi, T. Isolation of an anti-histaminic substance from green-lipped mussel (Perna canaliculus). Chem Pharm Bull.(Tokyo) 1986;34(11):4825-4828. View abstract.

Lau, S., Chiu, P. K., Chu, E. M. Y., Cheng, I. Y. W., Tang, W. M., Man, R. Y. K., and Halpern, G. M. Treatment of knee osteoarthritis with Lyprinol, lipid extract of the green-lipped mussel - a double-blind placebo-controlled study. Progress in Nutrition 2004;61(17):17-31.

Lawson, B. R., Belkowski, S. M., Whitesides, J. F., Davis, P., and Lawson, J. W. Immunomodulation of murine collagen-induced arthritis by N, N-dimethylglycine and a preparation of Perna canaliculus. BMC.Complement Altern Med 2007;7:20. View abstract.

MacKenzie, L., Holland, P., McNabb, P., Beuzenberg, V., Selwood, A., and Suzuki, T. Complex toxin profiles in phytoplankton and Greenshell mussels (Perna canaliculus), revealed by LC-MS/MS analysis. Toxicon 2002;40(9):1321-1330. View abstract.

Mani, S. and Lawson, J. W. In vitro modulation of inflammatory cytokine and IgG levels by extracts of Perna canaliculus. BMC.Complement Altern Med 2006;6:1. View abstract.

McPhee, S., Hodges, L. D., Wright, P. F., Wynne, P. M., Kalafatis, N., Harney, D. W., and Macrides, T. A. Anti-cyclooxygenase effects of lipid extracts from the New Zealand green-lipped mussel, Perna canaliculus. Comp Biochem Physiol B Biochem Mol.Biol 2007;146(3):346-356. View abstract.

Miles, C. O., Wilkins, A. L., Munday, R., Dines, M. H., Hawkes, A. D., Briggs, L. R., Sandvik, M., Jensen, D. J., Cooney, J. M., Holland, P. T., Quilliam, M. A., MacKenzie, A. L., Beuzenberg, V., and Towers, N. R. Isolation of pectenotoxin-2 from Dinophysis acuta and its conversion to pectenotoxin-2 seco acid, and preliminary assessment of their acute toxicities. Toxicon 2004;43(1):1-9. View abstract.

Morohashi, A., Satake, M., Naoki, H., Kaspar, H. F., Oshima, Y., and Yasumoto, T. Brevetoxin B4 isolated from greenshell mussels Perna canaliculus, the major toxin involved in neurotoxic shellfish poisoning in New Zealand. Nat Toxins. 1999;7(2):45-48. View abstract.

New Zealand green-lipped mussel extract (Seatone) and rheumatoid arthritis. N Z Med J 5-27-1981;93(684):343. View abstract.

Pollard, B., Guilford, W. G., Ankenbauer-Perkins, K. L., and Hedderley, D. Clinical efficacy and tolerance of an extract of green-lipped mussel (Perna canaliculus) in dogs presumptively diagnosed with degenerative joint disease. N Z Vet.J 2006;54(3):114-118. View abstract.

Scotti, P. D., Dearing, S. C., Greenwood, D. R., and Newcomb, R. D. Pernin: a novel, self-aggregating haemolymph protein from the New Zealand green-lipped mussel, Perna canaliculus (Bivalvia: Mytilidae). Comp Biochem Physiol B Biochem Mol.Biol 2001;128(4):767-779. View abstract.

Shiels, I. A. and Whitehouse, M. W. Lyprinol: anti-inflammatory and uterine-relaxant activities in rats, with special reference to a model for dysmenorrhoea. Allerg.Immunol (Paris) 2000;32(7):279-283. View abstract.

Sinclair, A. J., Murphy, K. J., and Li, D. Marine lipids: overview "news insights and lipid composition of Lyprinol". Allerg.Immunol.(Paris) 2000;32(7):261-271. View abstract.

Singh, M., Hodges, L. D., Wright, P. F., Cheah, D. M., Wynne, P. M., Kalafatis, N., and Macrides, T. A. The CO2-SFE crude lipid extract and the free fatty acid extract from Perna canaliculus have anti-inflammatory effects on adjuvant-induced arthritis in rats. Comp Biochem Physiol B Biochem Mol.Biol 2008;149(2):251-258. View abstract.

Suzuki, T., MacKenzie, L., Stirling, D., and Adamson, J. Pectenotoxin-2 seco acid: a toxin converted from pectenotoxin-2 by the New Zealand Greenshell mussel, Perna canaliculus. Toxicon 2001;39(4):507-514. View abstract.

Tenikoff, D., Murphy, K. J., Le, M., Howe, P. R., and Howarth, G. S. Lyprinol (stabilised lipid extract of New Zealand green-lipped mussel): a potential preventative treatment modality for inflammatory bowel disease. J Gastroenterol 2005;40(4):361-365. View abstract.

Torres, D. M., Tooley, K. L., Butler, R. N., Smith, C. L., Geier, M. S., and Howarth, G. S. Lyprinol only partially improves indicators of small intestinal integrity in a rat model of 5-fluorouracil-induced mucositis. Cancer Biol Ther 2008;7(2):295-302. View abstract.

Treschow, A. P., Hodges, L. D., Wright, P. F., Wynne, P. M., Kalafatis, N., and Macrides, T. A. Novel anti-inflammatory omega-3 PUFAs from the New Zealand green-lipped mussel, Perna canaliculus. Comp Biochem Physiol B Biochem Mol.Biol 2007;147(4):645-656. View abstract.

Whitehouse, M. W. Anti-TNF-alpha therapy for chronic inflammation: reconsidering pentoxifylline as an alternative to therapeutic protein drugs. Inflammopharmacology. 2004;12(3):223-227. View abstract.

Whitehouse, M. W., Macrides, T. A., Kalafatis, N., Betts, W. H., Haynes, D. R., and Broadbent, J. Anti-inflammatory activity of a lipid fraction (lyprinol) from the NZ green-lipped mussel. Inflammopharmacology. 1997;5(3):237-246. View abstract.

Wolyniak, C. J., Brenna, T., Murphy, K. J., and Sinclair, A. J. Gas chromatography-chemical ionization-mass spectrometric fatty acid analysis of a commercial supercritical carbon dioxide lipid extract from New Zealand green-lipped mussel (Perna canaliculus). Lipids 2005;40(4):355-360. View abstract.

Caughey, DE, Grigor RR, Caughey EB, et al. Perna canaliculus in the treatment of rheumatoid arthritis. Eur J Rheum Inflamm 1983;6:197-200. View abstract.

Cobb CS, Ernst E. Systematic review of a marine nutriceutical supplement in clinical trials for arthritis: the effectiveness of the New Zealand green-lipped mussel Perna canaliculus. Clin Rheumatol 2006;25:275-84. View abstract.

Couch RA, Ormrod DJ, Miller TE, Watkins WB. Anti-inflammatory activity in fractionated extracts of the green-lipped mussel. N Z Med J 1982;95:803-6. View abstract.

Emelyanov A, Fedoseev G, Krasnoschekova O, et al. Treatment of asthma with lipid extract of New Zealand green-lipped mussel: a randomised clinical trial. Eur Respir J 2002;20:596-600. View abstract.

Gibson RG, Gibson SL, Conway V, Chappell D. Perna canaliculus in the treatment of arthritis. Practitioner 1980;224:955-60. View abstract.

Gibson SL. The effect of a lipid extract of the New Zealand green-lipped mussel in three cases of arthritis. J Altern Complement Med 2000;6:351-4. View abstract.

Gibson SLM, Gibson RG. The treatment of arthritis with a lipid extract of Perna canaliculus: a randomised trial. Complement Ther Med 1998;6:122-6.

Highton TC, McArthur AW. Pilot study on the effect of New Zealand green mussel on rheumatoid arthritis. N Z Med J 1975;81:261-2. View abstract.

Huskisson EC, Scott J, Bryans R. Seatone is ineffective in rheumatoid arthritis. Br Med J 1981;282:1358-9. View abstract.

Larkin JG, Capell HA, Sturrock RD. Seatone in rheumatoid arthritis: a six-month placebo-controlled study. Ann Rheum Dis 1985;44:199-201. View abstract.

Miller T, Wu H. In vivo evidence for prostaglandin inhibitory activity in New Zealand green-lipped mussel extract. N Z Med J 1984;97:355-7. View abstract.

Miller TE, Dodd J, Ormrod DJ, Geddes R. Anti-inflammatory activity of glycogen extracted from Perna canaliculus (NZ green-lipped mussel). Agents Actions 1993;38 Spec No:C139-42. View abstract.

Murphy KJ, Mann NJ, Sinclair AJ. Fatty acid and sterol composition of frozen and freeze-dried New Zealand Green Lipped Mussel (Perna canaliculus) from three sites in New Zealand. Asia Pac J Clin Nutr 2003;12:50-60. View abstract.

Murphy KJ, Mooney BD, Mann NJ, et al. Lipid, FA, and sterol composition of New Zealand green lipped mussel (Perna canaliculus) and Tasmanian blue mussel (Mytilus edulis). Lipids 2002;37:587-95. View abstract.

Rainsford KD, Whitehouse MW. Gastroprotective and anti-inflammatory properties of green lipped mussel (Perna canaliculus) prepartion. Arzneimittelforschung 1980;30:2128-32. View abstract.

CONTINUE SCROLLING FOR RELATED SLIDESHOW

Health Solutions From Our Sponsors